Sign in
CompletedPhase 1

An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the pharmacokinetics of repeated doses of an approved antibiotic in healthy participants

Key facts

Who runs it
Cinclus Pharma Holding AB (publ)
Where
Sweden1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
12 people enrolled
Started
11 Nov 2025
Ended
22 Dec 2025
Type of study
Interventional
Record updated
11 November 2025

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Can take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
11 November 2025